ARCHIVES

Revlimid Maintenance Therapy Delayed Progression by 90%

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

Fisher and Redmond Subject Of Misconduct Investigation; ORI

May 6, 1994

Mass. Democrats, NCCS, To Provide Bracelets, Information In Honor Of Kennedy.

June 6, 2008

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

April 21, 2006

B.J. Kennedy, “Father of Medical Oncology,” Dead At 81

April 18, 2003

ELM’s CHOP-DS Aims For 15% Of Patients

September 13, 1985

In Brief: Judge Declines To Block NCI Contract Award

February 24, 1995